• ASB3 Drives MAVS Degradation to Suppress Antiviral Immunity

  2026-09-26

  A 2024 study identifies the E3 ubiquitin ligase ASB3 as a negative regulator of antiviral signaling: it promotes K48-linked ubiquitination of MAVS at K297 and its proteasomal degradation. Cell and animal experiments connect this mechanism to weaker type I interferon responses and greater influenza susceptibility, highlighting MAVS stability as a control point in host defense.

• Bufalin in TNBC: From Binding to Causal Evidence

  2026-09-25

  Bufalin is a cardiotonic steroid being investigated in triple-negative breast cancer research through a newly described STK33-degradation mechanism. This article explains how to distinguish target engagement from causal antitumor evidence and design experiments that test both.

• Alternariol: Reading Hepatic Toxicity Across Models

  2026-09-25

  Alternariol (AOH) can produce different biological readouts depending on the cell model, metabolic capacity, and endpoint measured. This guide connects emerging liver-fibrosis findings with practical assay decisions, helping researchers distinguish cellular stress, stellate-cell activation, and toxin detoxification.

• 5X Protein Loading Buffer (Reducing): SDS-PAGE Use

  2026-09-24

  5X Protein Loading Buffer (Reducing) prepares protein samples for denaturing, reducing SDS-PAGE by supplying SDS, a sulfhydryl reducing agent, buffer salts, and tracking dye. Use it when separation by apparent molecular weight is the goal; choose a non-reducing or native preparation when disulfide states, complexes, or native structure must be preserved.

• Negative α-Synuclein Condensates Shape Molecular Partitionin

  2026-09-24

  The study shows that α-synuclein condensates have a negative electrostatic potential that selectively enriches positively charged molecules, while charge repulsion can also limit condensate formation. Its in vitro and cell-based findings make probe charge an important variable when interpreting condensate localization and designing fluorescence experiments.

• AG-221 (Enasidenib) Workflows for IDH2-Mutant AML

  2026-09-23

  Build a mechanism-led acute myeloid leukemia research workflow with AG-221 (Enasidenib), connecting mutant IDH2 inhibition to 2-hydroxyglutarate reduction and differentiation readouts. Add CD44 and metabolic measurements to distinguish direct target engagement from broader cellular effects.

• ARCA for Synthetic mRNA Translation

  2026-09-23

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, is an orientation-selective Cap 0 analog for in vitro transcription. Product information reports approximately twofold higher translation than conventional m7G cap analogs and about 80% capping efficiency when used at a 4:1 molar ratio to GTP.

• Cytochalasin B in Host-Pathogen Entry Assays

  2026-09-22

  Cytochalasin B is more than an actin-disrupting reagent: it can help dissect how cytoskeletal dynamics shape microbial entry. This article translates a Drosophila S2 infection study into rigorous assay design, controls, and drug-discovery interpretation.

• Cy3 Maleimide for DNA Repair Assays

  2026-09-22

  Cy3 maleimide enables selective thiol labeling for fluorescence microscopy imaging and mechanistic DNA-repair assays. This article explains how to use the non-sulfonated dye alongside linker histone H1 research while distinguishing visualization from direct interaction mapping.

• G-1: Selective GPR30 Agonist for Mechanistic Studies

  2026-09-21

  G-1 enables controlled interrogation of rapid GPR30 signaling in calcium, migration, cardiovascular, and receptor-mechanism assays. This practical guide connects product specifications with dose selection, orthogonal controls, troubleshooting, and insights from a recent GPER ligand-interaction study.

• Mitocytosis, Mitophagy, and Myogenic Differentiation

  2026-09-21

  This study defines a damage-dependent sequence in which KIF5B-mediated mitocytosis, PINK1-dependent mitophagy, and caspase-3-mediated apoptosis cooperate to clear mitochondria during myogenic differentiation. Its gradient-damage design shows that moderate mitochondrial clearance can support myogenesis, while failure of compensatory pathways compromises myotube formation and cellular homeostasis.

• Liproxstatin-1 Workflows for Ferroptosis Research

  2026-09-20

  Liproxstatin-1 is a pathway-focused ferroptosis inhibitor for separating lipid-peroxidation-driven death from apoptosis and nonspecific oxidative injury. This guide translates its nanomolar cell protection into practical workflows for GPX4-deficient systems, renal injury models, and carefully bounded Candida albicans experiments.

• IR-1061: Near Infrared Fluorescent Dye Workflow

  2026-09-19

  IR-1061 combines OTN-NIR fluorescence with a formulation strategy suited to deep-tissue optical imaging, especially when low background and aqueous dispersion are priorities. This guide translates its handling requirements and PEG-b-PCL nanoparticle precedent into practical preparation, QC, optimization, and troubleshooting workflows.

• EZ Cap Cy5 Firefly Luciferase mRNA for Dual Readouts

  2026-09-18

  EZ Cap Cy5 Firefly Luciferase mRNA combines functional luciferase expression with direct Cy5 tracking in one transcript. This article presents a decision framework for separating delivery, intracellular trafficking, and translation performance in advanced mRNA experiments.

• H1 Phosphorylation Repairs Replication Fork Damage

  2026-09-17

  The reference study identifies S-phase phosphorylation of linker histone H1 as an active regulator of repair at collapsed replication forks. Through mutant analysis, site-specific photocrosslinking, and cellular rescue experiments, it connects phosphorylated H1 with ssDNA assembly, HPF1 recruitment, reduced histone PARylation, and improved resistance to replication-associated damage.

8353 records 3/557 page Previous Next 12345 下5页 Last page